The Serum Institute of India (SII) has said it will try to supply more doses of the AstraZeneca vaccine to the UK later based on the requirements in India. This comes despite a controversy surrounding supplies of the vaccines.
A company spokesperson said, “Five million doses had been delivered a few weeks ago to the UK and we will try to supply more later, based on the current situation and requirement for the government immunisation programme in India.”
A London-based daily had quoted SII Chief Executive Officer Adar Poonawalla saying exports to the UK would resume once the
A company spokesperson said, “Five million doses had been delivered a few weeks ago to the UK and we will try to supply more later, based on the current situation and requirement for the government immunisation programme in India.”
A London-based daily had quoted SII Chief Executive Officer Adar Poonawalla saying exports to the UK would resume once the

)